Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
deals
9
×
fda
9
×
investing
9
×
life sciences
national blog main
san diego blog main
san diego top stories
9
×
startups
boston blog main
boston top stories
national top stories
new york blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
cancer
clinical trials
pfizer
duchenne muscular dystrophy
merck
nonalcoholic steatohepatitis
alzheimer's disease
amag pharmaceuticals
What
roundup
bio
cancer
develop
drug
ahead
amid
asco
bombast
business
caught
coronavirus
days
debate
discussion
disease
drugs
efforts
fda
growing
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
time
tuesday’s
vaccine
viewers
acquire
adding
alliance
ambien
american
annual
approved
atrial
attendees
Language
unset
Current search:
biotech
×
deals
×
investing
×
fda
×
" san diego top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More